The CAS number for BPC-157 is 137525-51-0
Treatment stage What may be common What deserves attention Week 1 Nausea, fullness, reduced appetite, bloating, indigestion, diarrhea, constipation, fatigue Repeated vomiting, severe pain, inability to stay hydrated Weeks 2 to 4 Early symptoms may settle, persist, or fluctuate Symptoms interfering with eating, drinking, or daily function Weeks 5 to 8 Symptoms may reappear after clinician-directed dose escalation A significant return or worsening of gastrointestinal symptoms Months 2 to 3 Some patients tolerate treatment more comfortably
C.ChambersE
doi: 10.1146/annurev-pharmtox-101018-112717, 94 IslerB.von BurgN.KleinjungT.MeyerM.StmpfliP.ZlchN.et al
Fiber MGP provides 11g of fiber strategically designed for gentle digestion and optimal tolerance
Weight loss stalled on Retatrutide